Covestor’s Voyager Therapeutics VYGR Stock Holding History

Covestor’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-101	Closed	-$1K	–	2794
2024 Q3	$1K	Buy	+101	New	+$734	﹤0.01%	2122

Other funds holding VYGR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covestor's VYGR Position: Q4 2024 in Review

Covestor sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 101 shares — an estimated $1K sold.

Covestor first reported a position in VYGR in Q3 2024 and held it in 1 quarter. The position peaked at $1K in Q3 2024. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.

Covestor reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
Covestor sold 101 Voyager Therapeutics shares in Q4 2024, an estimated $1K.
Covestor first reported a position in Voyager Therapeutics in Q3 2024 and held it in 1 quarter.
Covestor's Voyager Therapeutics position peaked at $1K in Q3 2024.
132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.

Based on Covestor's 13F filing for Q4 2024, filed 13 Feb 2025.